Quality by Design (QbD) in Pharmaceuticals Quality by Design (QbD) represents a methodical approach to pharmaceutical development that prioritizes process understanding and proactive risk management from the very beginning. Rather than relying on reactive end-product testing, QbD ensures that quality is built into pharmaceutical products by design. This approach—often referred to as quality by design […]
Tag: pharma
The State of Pharma Production in Belgium
In the face of Belgium’s industrial downturn, a shining beacon of innovation and resilience emerges from its pharmaceutical sector. Bucking the trend of the country’s declining industrial production, the pharmaceutical industry is not only surviving but thriving, carving a distinct niche for itself on the global stage. This industry’s success is a testament to the […]
U.S. Pharma Companies’ Readiness For Domestic Life Science Manufacturing
In the realm of pharmaceuticals, the question arises: are U.S. pharma companies prepared to shift their life science manufacturing operations back home? This query delves into the potential implications of such a move, considering factors like advancements in robotics for hazardous tasks and the development of hardware/software architectures inspired by autonomous driving technologies. While fully […]
Kemira Expands Sodium Borohydride Production Capacity
Biotech powerhouse, Kemira Oyj, headquartered in the Nordic capital of Helsinki, Finland, has announced a strategic expansion of its sodium borohydride (SBH) powder production capacity at the Äetsä site. This investment, which includes the establishment of a new production line and substantial upgrades in process safety, is budgeted under €10 million. It’s a strategic move […]
UCB Invests Billions in U.S. Pharma Factory Expansion
UCB, the Belgian pharmaceutical titan, has revealed ambitious plans to significantly bolster its U.S. operations. Building upon its recent successes in the American market, UCB has charted a strategic course that includes investing billions in a new state-of-the-art manufacturing facility. The move is a testament to UCB’s robust growth in the U.S. market that has […]
Bayer’s Stock Surges 40% After Years of Losses
In a dramatic reversal of fortune that has captivated the world of biotechnology, Bayer, the renowned pharmaceutical and chemical conglomerate, has made an inspiring comeback, illustrating the tenacity of the human spirit and the resilience of the biotech industry. After several years of financial turbulence and a reputation as one of Germany’s least promising stocks, […]
Aurobindo Pharma Expands with New US Subsidiary
In a strategic move that underlines its global ambitions, Hyderabad-based Aurobindo Pharma Limited has announced the incorporation of a new wholly owned subsidiary in the United States. Aurobindo Pharma, a leading pharmaceutical company, is known for its diverse product portfolio that includes CNS, Anti-Retroviral, CVS, Antibiotics, Gastroenterological, Anti-Diabetics, and Anti-Allergic areas. The company, with over […]
Impact of US Tariff Threats on Indian Pharma Stocks
As the summer sun climbs high in the Indian sky, a storm is gathering on the financial horizon. The Nifty Pharma index, an indicator of the health of India’s pharmaceutical sector, is being tossed about in a tempest of uncertainty. The cause? An announcement by US President Donald Trump that tariffs, those economic barbs that […]
Medium-Term Triggers for Aurobindo Pharma’s Upside Potential
Aurobindo Pharma’s share price could see a 35% increase due to five key medium-term triggers. These triggers are expected to positively impact the company’s performance and drive growth in the pharmaceutical sector. With a focus on innovation and strategic investments, Aurobindo Pharma is poised for significant gains in the near future. In the competitive pharmaceutical […]
Exploring Astellas Pharma Innovations
In the high-stakes world of pharmaceuticals, where the quest for the next groundbreaking therapy is relentless, Astellas Pharma has carved out a niche for itself, consistently delivering cutting-edge medical innovations. The company’s name has become synonymous with advanced treatments that not only push the boundaries of scientific discovery but also significantly improve patient outcomes and […]
Astellas Pharma Inc. & Mitsubishi Research Institute Collaboration for Pharma Startups in Japan
In a dynamic move set to galvanize the Japanese pharmaceutical sector, Astellas Pharma Inc. and Mitsubishi Research Institute (MRI) have announced a strategic alliance aimed at fostering the growth of pharmaceutical startups in Japan. This partnership is a testament to the shared commitment of both organizations to harness their collective expertise and resources to cultivate […]
Analysts Provide Healthcare Insights: Pfizer and Sagimet Biosciences
In the dynamic world of healthcare, where rapid advancements in therapeutics and precision medicine hold the potential to reshape entire industries, informed analysis is not just valuable, it is crucial. The healthcare landscape is vast, and navigating its intricate maze requires the guidance of keen observers who have their fingers firmly on the pulse of […]
Ascendis Pharma’s 10-Year Stock Growth
Over the past decade, Ascendis Pharma has set itself apart as a force to be reckoned with in the pharmaceutical industry. Demonstrating remarkable resilience and an unwavering commitment to innovation, the company has consistently outshone its market peers. With an annualized outperformance of 14.45%, Ascendis Pharma has confidently navigated the competitive biotech landscape, yielding an […]
Unlocking Browser Permissions for Ajinomoto Bio-Pharma
In the dynamic landscape of biopharmaceutical innovation, Ajinomoto Bio-Pharma Services (ABS) has firmly established itself as a vanguard of progress. A subsidiary of the Tokyo-based Ajinomoto Co., Inc., this global, fully integrated contract development and manufacturing organization (CDMO) is consistently pushing the envelope of pharmaceutical advancement. But to truly appreciate the depths of their pioneering […]
Expanding Pharmaceutical Opportunities in Africa
Africa’s pharmaceutical industry is currently in the throes of a monumental expansion, marking a new epoch of opportunity and growth. This transformative period is fueled by an amplified focus on healthcare and the democratization of medical access across the continent. With this evolution, Africa is now stepping up to the global stage, primed to become […]
Integrating Intelligence into Pharma Packaging
In the rapidly evolving world of pharmaceuticals, a new frontier of innovation is emerging: Smart pharma packaging. This ingenious fusion of technology and traditional packaging is revolutionizing the industry’s approach to product security, supply chain efficiency, and patient safety. As the pharmaceutical landscape becomes increasingly globalized and complex, the need for such advanced measures is […]
Optimizing Antibody Formulation for Drug Development
In the realm of drug development, the last lap of the race – formulating antibodies – is a Herculean task, akin to threading a microscopic needle while riding a roller coaster. It’s a scientific juggling act requiring the ultimate precision, balance, and control. Christy Eatmon, a global subject matter connoisseur from Thermo Fisher Scientific, reveals […]
Zealand Pharma’s Positive Results: 28-Week GLP-1/GLP-2 Trial
Zealand Pharma, a pioneering biotechnology company focused on peptide-based medicines, recently announced compelling results from a 28-week Phase 1b trial involving the innovative GLP-1/GLP-2 receptor dual agonist, dapiglutide. As a dual agonist, dapiglutide represents a significant leap in the realm of obesity treatment, revealing a unique approach to address obesity-related comorbidities driven by low-grade inflammation. […]
Chinese Pharma Firms Adapt to US Trade Pressures
Amid the rising crescendo of international trade tensions, particularly between the colossal economies of China and the United States, a fascinating metamorphosis is underway in the pharmaceutical industry. Chinese pharma firms, demonstrating remarkable resilience and dexterity, have been subtly shifting their strategic bearings to stay afloat in this turbulent economic ocean. In a world where […]
Innovator Oligonucleotide Licensing Trends in CNS Therapeutics
In the biopharmaceutical arena, the spotlight is increasingly shining on the pioneering field of oligonucleotide therapeutics. The race is on as pharmaceutical titans such as AbbVie, Lilly, Roche, and Takeda display burgeoning interest in licensing innovator oligonucleotides for central nervous system (CNS) indications. This nascent trend is underscored by a staggering 339% surge in total […]
Ascentage Pharma Presents Alrizomadlin Data at ASCO 2025
Ascentage Pharma recently unveiled promising clinical data on the use of Alrizomadlin as a monotherapy and in combination therapies for solid tumors at ASCO 2025. The presentation highlighted the company’s optimistic outlook and strategic plans for future developments in the pharmaceutical industry. Ascentage Pharma’s forward-looking statements, as per the regulations, express the company’s views on […]
Nxera Pharma Receives $15 Million from Neurocrine Biosciences for Phase 3 Trial of NBI-1117568
In a significant development, Nxera Pharma Group has secured a substantial investment of $15 million from Neurocrine Biosciences following the dosing of the first patient in the Phase 3 trial of NBI-1117568. This strategic alliance marks a crucial milestone in the discovery, development, and potential commercialization of innovative pharmaceutical products. However, investors should be aware […]
Piramal Pharma Canada Unit Receives NAI from USFDA
Piramal Pharma Limited’s stock surged after the announcement that the US Food and Drug Administration (USFDA) granted a Form 483 with zero observations and a No Action Indicated (NAI) status for its Aurora facility in Canada. This regulatory approval signifies the facility’s compliance with stringent quality standards, paving the way for potential market expansion and […]
